Kairos Pharma (KAPA) Assets (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Assets came in at $6.5 million in Q4 2025, up 13.38% YoY from $5.8 million in Q4 2024, and down 1.99% on a QoQ basis from $6.7 million in Q2 2025.
Kairos Pharma (KAPA) Assets (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Assets data on file, last reported at $6.5 million in Q4 2025.
- Quarterly Assets rose 13.38% year-over-year to $6.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.5 million (up 13.38% YoY) and the FY2025 annual result came in at $6.5 million, up 13.38% from the prior year.
- Assets declined to $6.5 million in Q4 2025, from $6.7 million in the prior quarter.
- In the past five years, Assets ranged from a high of $7.9 million in Q1 2025 to a low of $965000.0 in Q4 2023.
- A 3-year average of $5.5 million and a median of $6.2 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets jumped 497.72% — and 2025, when it increased 13.38%.
- Tracing KAPA's Assets over 3 years: stood at $965000.0 in 2023, then jumped by 497.72% to $5.8 million in 2024, then increased by 13.38% to $6.5 million in 2025.
- The last three Assets figures came in at $6.5 million (Q4 2025), $6.7 million (Q2 2025), and $7.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Kairos Pharma | 5.50 Mn | 168,380.07 | - | 6.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.54 Mn |
| Jun 30, 2025 | 6.67 Mn |
| Mar 31, 2025 | 7.94 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Dec 31, 2023 | 965,000.00 |